Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lymph-Flo is a medical device company dedicated to developing innovative solutions for the management of chronic lymphedema. The company's flagship technology is an implantable, automated pump system designed to actively move excess lymphatic fluid from affected limbs back into the venous circulation. By providing a continuous, internal drainage mechanism, Lymph-Flo aims to significantly reduce limb volume and alleviate the symptoms of patients who do not respond to traditional external compression therapies. The system represents a physiological approach to treating lymphatic obstruction, potentially offering a long-term surgical alternative to lifelong manual drainage and compression garments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LYMPH-FLO.